Gregory L. Weaver, Chief Financial Officer at Altimmune, Inc. (ALT), bought 5,000 shares at $3.54 ($18K) on 2026-03-06, disclosed to the SEC on 2026-03-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ATOS | SELL | 2023-11-17 | $33K | — | Filing → |
| ATOS | BUY | 2023-06-20 | $49K | — | Filing → |
| ATOS | SELL | 2021-07-07 | $1.2M | — | Filing → |